Supreme Petrochem Ltd
SPLPETROSupreme Petrochem Ltd's earnings have outrun its stock. EPS grew +461.2% in a year against a −14.1% price move.
The sharpest disagreement: annual EPS moved +461.2% against a −14.1% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (15 weeks in). Underneath, the last four quarters read improving — profit +190.2% year on year, and 85% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Supreme Petrochem Ltd trades at ₹713, in a confirmed uptrend and 15 weeks into that stage. That is +1.2% against its own 200-day average. It sits at 57% of a 52-week range of ₹501 to ₹870. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (1 week and counting).
Today the stock is in a confirmed uptrend — week 15 of stage 2, confirmed. At ₹713 it trades +1.2% versus its 200-day average and sits at 57% of its 52-week range (₹501–₹870).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +1,187% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (1 week and counting; last ahead the week of 2026-07-24) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Supreme Petrochem Ltd trades at 27.2× P/E, against too little history to rank. Its long-run median P/E is 40.6×, measured across 0.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 27.2× is against too little history to rank, against a long-run median of 40.6× measured over 0.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +461.2% against a −14.1% price move — earnings outran the price, pushing the multiple DOWN its own range.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read.
Supreme Petrochem Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE lifting at 30.0% — the per-curve reads carry the story. The read is built from 12 quarters across 4 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
4-Factor Sector Score
64.0/100 — rank 3 of 7 in Petrochem - Polymers · 84% evidence confidence
Supreme Petrochem Ltd scores 64.0 out of 100 against the 7 companies it is compared with in Petrochem - Polymers, ranking 3. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 20.3 + 15.8 + 14.1 + 13.8 = 64. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Supreme Petrochem Ltd reported ₹1,715 Cr of revenue in the Jun 26 quarter, +22.3% year on year. That is the 2nd straight quarter of year-on-year growth. Over 20 years it has compounded at 6.9% a year. The last full year, Mar 26, came in at ₹5,406 Cr. The last four reported quarters add to ₹5,720 Cr.
Mar 26 revenue came in at ₹5,406 Cr (+235.2% on the year), capping 20 years at 6.9% compound. The latest quarter (Jun 26) printed ₹1,715 Cr, +22.3% year on year — the 2nd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged −1.9% growth against the decade's 6.9% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −2.1% over the last 4 quarters against +1.1%/yr over the last 8 — rolling over; TTM profit +38.9% vs +10.2%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Supreme Petrochem Ltd's operating margin is 19.0% in the Jun 26 quarter, +11.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 6 fiscal years the operating margin has ranged 3.1% to 10.0%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 19.0%, +11.0 pp against the same quarter a year ago. Across 6 fiscal years the operating margin has ranged 3.1%–10.0%, and Mar 26's 10.0% is the top of that band — a record year.
Why the margin moved: operating margin went +11.1 pp year on year while gross margin went +10.4 pp — the gain came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Supreme Petrochem Ltd earned ₹238 Cr of net profit in the Jun 26 quarter, +190.2% year on year. It is the 2nd consecutive quarter of growth. Full-year Mar 26 profit was ₹330 Cr. The 20-year compound rate is 16.0%. That is 13.9% of the quarter's revenue. The same quarter a year earlier earned ₹82.0 Cr.
Jun 26 profit was ₹238 Cr, +190.2% year on year — the 2nd consecutive quarter of growth. On the full year, Mar 26 printed ₹330 Cr (+450.0%), and the 20-year compound rate is 16.0%.
Why profit moved: revenue contributed +22.3% and the margin +11.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +36.3% vs revenue −1.9%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 85% of Supreme Petrochem Ltd's reported profit arrived as operating cash — the cash follows the profit. In Mar 26 that was ₹247 Cr of operating cash against ₹330 Cr of profit. Cash resolution here is annual, because quarterly cash statements are not published.
Mar 26: operating cash of ₹247 Cr against reported profit of ₹330 Cr. Across the last 3 fiscal years the conversion rate is 85% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 85%: the cash cycle stretched 13 days between FY06 and Mar 26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Supreme Petrochem Ltd's cash conversion cycle runs 21 days in Mar 26, up from 8 days in FY06. Capital spending ran ₹74.0 Cr over the last 3 years. At Mar 26 sales of ₹5,406 Cr each day of that cycle holds about ₹14.8 Cr, so roughly ₹311 Cr sits inside the business at any moment.
Mar 26: debtors at 35 days, inventory at 51 days — roughly 1.7 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 21 days, looser than FY06's 8.
The full loop: cash goes out to suppliers and production on day 0; stock waits 51 days to sell; customers pay about 35 days after that; and suppliers themselves are paid at 65 days — netting out to the 21-day cycle.
In money terms: at Mar 26 sales of ₹5,406 Cr, each day of the cycle holds about ₹14.8 Cr — so the 21-day loop keeps roughly ₹311 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹74.0 Cr over the last 3 fiscal years against ₹55.0 Cr of depreciation — building somewhat ahead of wear-and-tear. Capital work-in-progress stands at ₹29.0 Cr (FY10) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Supreme Petrochem Ltd earns a ROCE of 30% in FY10. That is up from a trough of 13% in FY08. Return on invested capital clears the cost of that capital by +14.9 percentage points, so growth here adds value rather than only size. The wiring behind it is 6.1% net margin on 1.55× asset turns.
FY10 ROCE is 30%, recovered from a FY08 trough of 13% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (Mar 26): 6.1% net margin × 1.55× asset turns × 1.47× balance-sheet leverage ≈ 13.9% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 26.9% − 12.0% = a +14.9 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. A spread this wide means every rupee reinvested creates more than a rupee of value — the engine compounds.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Supreme Petrochem Ltd carries total debt of ₹133 Cr against shareholder equity of ₹2,378 Cr as of Mar 26, a debt-to-equity of 0.06 — effectively unlevered. On the annual view that ratio went from 0.02 in FY22 to 0.06 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹133 Cr against shareholder equity of ₹2,378 Cr — a debt-to-equity of 0.06. On the annual view, debt-to-equity went from 0.02 (FY22) to 0.06 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Domestic institutions added 1.5 points of Supreme Petrochem Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 4.1% of the company. Foreign institutions moved +0.8 points over the same window, to 3.8%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: +1.5 points over 8 quarters to 4.1%; Foreign institutions: +0.8 points over 8 quarters to 3.8%; Promoters: +0.0 points over 8 quarters to 64.2%.
Why the register moved: domestic institutions drove it (+1.5 points), alongside foreign institutions (+0.8 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Supreme Petrochem Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Bhansali Engineering Polymers LtdBEPL | 70.3/100Favorable setup87% evidence | TURNING | 21.5/35 Revenue 5.4% · PAT 15.6% · OPM change 0 pp 100% evidence | 17.9/25 ROCE 23.8% · OPM 17% 100% evidence | 15.9/20 P/E 14.4× · PEG 0.32 65% evidence | 15.0/20 RS sector 1.9% · RS bench 19.2% · 1Y 6%9 of 10 weeks ahead 70% evidence |
| Exact sum: 21.5 + 17.9 + 15.9 + 15 = 70.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Kothari Petrochemicals LtdKOTHARIPET | 65.6/100Favorable setup83% evidence | FADING | 17.7/35 Revenue 2.3% · PAT 12.3% · OPM change 1 pp 83% evidence | 21.4/25 ROCE 28.6% · OPM 16% 95% evidence | 13.2/20 P/E 11.3× · PEG — 50% evidence | 13.3/20 RS sector 1.3% · RS bench 4.4% · 1Y -17%4 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 21.4 + 13.2 + 13.3 = 65.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Supreme Petrochem Ltdthis pageSPLPETRO | 64.0/100Mixed-positive evidence84% evidence | ASLEEP | 20.3/35 Revenue -2.1% · PAT 38.9% · OPM change 11 pp 95% evidence | 15.8/25 ROCE 17.6% · OPM 19% 95% evidence | 14.1/20 P/E 27.2× · PEG 0.73 65% evidence | 13.8/20 RS sector 29.5% · RS bench -0.8% · 1Y -10.9%2 of 10 weeks ahead 70% evidence |
| Exact sum: 20.3 + 15.8 + 14.1 + 13.8 = 64 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Manali Petrochemicals LtdMANALIPETC | 58.3/100Mixed-positive evidence76% evidence | BREAKING OUT | 23.1/35 Revenue 14.2% · PAT 100% · OPM change 0 pp 83% evidence | 9.1/25 ROCE 7.2% · OPM 9% 95% evidence | 10.3/20 P/E 15.7× · PEG — 15% evidence | 15.8/20 RS sector 1.5% · RS bench 4.5% · 1Y -11%11 of 12 weeks ahead 100% evidence |
| Exact sum: 23.1 + 9.1 + 10.3 + 15.8 = 58.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Styrenix Performance Materials LtdSTYRENIX | 48.1/100Mixed-negative evidence90% evidence | TURNING | 15.7/35 Revenue 15.3% · PAT -20.5% · OPM change 5 pp 88% evidence | 11.7/25 ROCE 15.1% · OPM 14% 100% evidence | 12.3/20 P/E 23.6× · PEG 1.68 100% evidence | 8.4/20 RS sector -9.6% · RS bench 9.8% · 1Y -19.1%8 of 11 weeks ahead 70% evidence |
| Exact sum: 15.7 + 11.7 + 12.3 + 8.4 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Chemplast Sanmar LtdCHEMPLASTS | 31.1/100Adverse evidence68% evidence | BASING | 16.3/35 Revenue -2.8% · PAT -80% · OPM change 11.8 pp 65% evidence | 4.8/25 ROCE 0.3% · OPM 15% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 0.0/20 RS sector -35.5% · RS bench -33.9% · 1Y -55.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 4.8 + 10 + 0 = 31.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7NOCIL LtdNOCIL | 22.6/100Adverse evidence96% evidence | ASLEEP | 5.5/35 Revenue -6.5% · PAT -46.6% · OPM change -4 pp 88% evidence | 5.3/25 ROCE 3.9% · OPM 6% 100% evidence | 8.8/20 P/E 59.6× · PEG 0.97 100% evidence | 3.0/20 RS sector -5.4% · RS bench -2.3% · 1Y -11.1%6 of 12 weeks ahead 100% evidence |
| Exact sum: 5.5 + 5.3 + 8.8 + 3 = 22.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Supreme Petrochem Ltd's share price today?
Supreme Petrochem Ltd trades at ₹713, −14.1% over the past year. The company is valued at ₹13,410 Cr. The stock sits at 57% of its 52-week range of ₹501–₹870, +1.2% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 15 weeks in. — as of 31 July 2026.
What were Supreme Petrochem Ltd's latest quarterly results?
Supreme Petrochem Ltd reported revenue of ₹1,715 Cr and net profit of ₹238 Cr for the Jun 26 quarter. Revenue rose 22.3% and profit rose 190.2% year on year. Earnings per share were ₹12.62. The operating margin was 19.0%, 11.0 pp higher than a year earlier. — as of 31 July 2026.
What is Supreme Petrochem Ltd's revenue?
Supreme Petrochem Ltd reported revenue of ₹1,715 Cr in the Jun 26 quarter, +22.3% year on year. For the full Mar 26 fiscal year, revenue was ₹5,406 Cr (+235.2%). Over the last 20 years revenue compounded at 6.9% a year. — as of 31 July 2026.
What is Supreme Petrochem Ltd's profit?
Supreme Petrochem Ltd earned ₹238 Cr of net profit in the Jun 26 quarter, +190.2% year on year — the 2nd straight quarter of growth. Full-year Mar 26 profit was ₹330 Cr. The operating margin ran 19.0% in the latest quarter. — as of 31 July 2026.
What is Supreme Petrochem Ltd's market cap?
Supreme Petrochem Ltd's market capitalisation is ₹13,410 Cr at a share price of ₹713. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
Does Supreme Petrochem Ltd pay a dividend?
Yes — Supreme Petrochem Ltd's dividend payout was 60% of profit in FY26, and it recorded a payout in each of its last 6 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Supreme Petrochem Ltd growing?
Yes — Supreme Petrochem Ltd is growing: latest-quarter revenue +22.3% year on year, profit +190.2%, and the margin +11.0 pp at 19.0%. The 20-year compound rates are 6.9% (revenue) and 16.0% (profit). The earnings engine currently reads: improving — as of 31 July 2026.
How is Supreme Petrochem Ltd performing?
Supreme Petrochem Ltd is in a confirmed uptrend, 15 weeks in. Its latest quarter's revenue rose 22.3% and profit rose 190.2% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is Supreme Petrochem Ltd in?
Mixed — no clean majority across the growth curves, ROCE lifting at 30.0% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth −2.1% latest, profit growth +38.9% latest, eps growth +38.5% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Supreme Petrochem Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 15 of stage 2), trading +1.2% versus its 200-day average and at 57% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Supreme Petrochem Ltd beating the market?
Not lately — on a trailing-13-week view Supreme Petrochem Ltd is currently behind the NIFTY 500 (1 week and counting; last ahead the week of 2026-07-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +1,187% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.
Will Supreme Petrochem Ltd's share price go up?
This page publishes no price forecast for Supreme Petrochem Ltd. What it measures instead: the share price is ₹713, the price is in a confirmed uptrend 15 weeks in. Direction is not something this site claims to know. — as of 31 July 2026.
Who owns Supreme Petrochem Ltd?
Promoters hold 64.2% of Supreme Petrochem Ltd, foreign institutions 3.8%, domestic institutions 4.1% and the public 27.7% (latest quarter). The biggest move on the register over the last two years: Domestic institutions added 1.5 points over 8 quarters. — as of 31 July 2026.
Does Supreme Petrochem Ltd have too much debt?
No — Supreme Petrochem Ltd's debt-to-equity is 0.06, and operating profit covers the interest bill 29×. Mar 26 borrowings were ₹133 Cr against equity of ₹2,377 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.
What is Supreme Petrochem Ltd's capex?
Supreme Petrochem Ltd spent ₹74.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY10 alone that was ₹21.0 Cr, with ₹29.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Supreme Petrochem Ltd's cash flow?
Supreme Petrochem Ltd generated ₹247 Cr of operating cash flow in Mar 26. Reported profit that year was ₹330 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Supreme Petrochem Ltd's profit real cash?
Yes — over the last 3 fiscal years, 85% of Supreme Petrochem Ltd's reported profit arrived as operating cash. In Mar 26, operating cash was ₹247 Cr against reported profit of ₹330 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Supreme Petrochem Ltd in its business cycle?
Supreme Petrochem Ltd's Mar 26 operating margin was 10.0%, against a 6-year band of 3.1%–10.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 19.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Supreme Petrochem Ltd story?
The sharpest disagreement: annual EPS moved +461.2% against a −14.1% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Supreme Petrochem Ltd a stock worth studying right now?
This is not investment advice. The machine read: Supreme Petrochem Ltd's earnings have outrun its stock. EPS grew +461.2% in a year against a −14.1% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.